We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Adaptive Biotechnologies
ADPT
$3.97B
| $12.2M | 0.01% |
251,758
+15,637
| +7% | +$570K |
|
1352
Advanced Energy
AEIS
$13B
| $12.2M | 0.01% |
179,665
-2,947
| -2% | -$176K |
|
1353
Moog Inc Class A
MOG.A
$12.8B
| $12.2M | 0.01% |
229,891
-311,113
| -58% | -$16M |
|
1354
Protolabs
PRLB
$2.13B
| $12.2M | 0.01% |
108,208
+917
| +0.9% | +$94.1K |
|
1355
Hamilton Lane
HLNE
$5.57B
| $12.2M | ﹤0.01% |
180,488
+41,852
| +30% | +$2.64M |
|
1356
Travere Therapeutics
TVTX
$5.78B
| $12.2M | ﹤0.01% |
595,533
+34,000
| +6% | +$541K |
|
1357
Century Communities
CCS
$2.03B
| $12.1M | ﹤0.01% |
395,266
-122,883
| -24% | -$2.94M |
|
1358
Marten Transport
MRTN
$1.22B
| $12.1M | ﹤0.01% |
720,195
-64,046
| -8% | -$1.01M |
|
1359
Medifast
MED
$141M
| $12.1M | ﹤0.01% |
86,935
+19,304
| +29% | +$1.77M |
|
|
AIMC
1360
DELISTED
Altra Industrial Motion Corp
AIMC
| $12M | ﹤0.01% |
377,844
+971
| +0.3% | +$25.7K |
|
|
NSTG
1361
DELISTED
NanoString Technologies, Inc.
NSTG
| $12M | ﹤0.01% |
408,396
-145,449
| -26% | -$4.33M |
|
1362
Central Pacific Financial
CPF
$1B
| $12M | ﹤0.01% |
746,745
+167,379
| +29% | +$2.66M |
|
1363
GSK
GSK
$106B
| $11.9M | ﹤0.01% |
234,331
-3,099,721
| -93% | -$159M |
|
|
AVYA
1364
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $11.9M | ﹤0.01% |
965,261
+32,751
| +4% | +$377K |
|
1365
Pricesmart
PSMT
$5.46B
| $11.9M | ﹤0.01% |
197,451
-2,777
| -1% | -$160K |
|
1366
Alcoa
AA
$13.2B
| $11.9M | ﹤0.01% |
1,058,775
+267,519
| +34% | +$2.39M |
|
|
BIG
1367
DELISTED
Big Lots, Inc.
BIG
| $11.9M | ﹤0.01% |
283,131
-37,360
| -12% | -$1.06M |
|
1368
Amkor Technology
AMKR
$13.7B
| $11.9M | ﹤0.01% |
964,111
+141,441
| +17% | +$1.46M |
|
1369
NETGEAR
NTGR
$635M
| $11.9M | ﹤0.01% |
458,210
+26,922
| +6% | +$655K |
|
|
CADE
1370
DELISTED
Cadence Bank
CADE
| $11.9M | ﹤0.01% |
521,519
+53,609
| +11% | +$1.14M |
|
1371
Invesco
IVZ
$13.9B
| $11.8M | ﹤0.01% |
1,101,163
-125,583
| -10% | -$1.13M |
|
|
GLDD
1372
DELISTED
Great Lakes Dredge & Dock
GLDD
| $11.8M | ﹤0.01% |
1,278,667
-72,412
| -5% | -$633K |
|
|
TSE
1373
DELISTED
Trinseo
TSE
| $11.8M | ﹤0.01% |
533,183
-1,158
| -0.2% | -$23.7K |
|
|
MRSN
1374
DELISTED
Mersana Therapeutics
MRSN
| $11.8M | ﹤0.01% |
20,118
+12,387
| +160% | +$4.23M |
|
1375
Papa John's
PZZA
$806M
| $11.7M | ﹤0.01% |
147,639
-7,877
| -5% | -$586K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.